Total Payments
$13,459
2024 Payments
$3,362
Companies
38
Transactions
677
Medicare Patients
1,867
Medicare Billing
$401,890
Payment Breakdown by Category
Food & Beverage$13,360 (99.3%)
Education$98.99 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,360 | 676 | 99.3% |
| Education | $98.99 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,889 | 91 | $0 (2024) |
| ABBVIE INC. | $1,656 | 95 | $0 (2024) |
| UCB, Inc. | $1,552 | 68 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,133 | 51 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $751.40 | 33 | $0 (2024) |
| PFIZER INC. | $642.20 | 42 | $0 (2024) |
| Janssen Biotech, Inc. | $629.53 | 32 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $518.78 | 28 | $0 (2024) |
| Genentech USA, Inc. | $454.70 | 43 | $0 (2024) |
| Radius Health, Inc. | $443.50 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,362 | 154 | ABBVIE INC. ($557.51) |
| 2023 | $3,042 | 155 | Amgen Inc. ($560.84) |
| 2022 | $2,140 | 103 | UCB, Inc. ($301.08) |
| 2021 | $1,745 | 90 | Amgen Inc. ($276.33) |
| 2020 | $1,615 | 95 | GENZYME CORPORATION ($210.72) |
| 2019 | $1,481 | 78 | Novartis Pharmaceuticals Corporation ($211.79) |
| 2017 | $73.52 | 2 | Amgen Inc. ($62.74) |
All Payment Transactions
677 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $45.92 | General |
| Category: Immunology | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $16.48 | General |
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/10/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Endocrinology | ||||||
| 11/27/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Bone Health | ||||||
| 11/26/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: Immunology | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: Immunology | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Immunology | ||||||
| 11/13/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/08/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Immunology | ||||||
| 10/26/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.26 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 627 | 7,275 | $413,690 | $179,266 |
| 2022 | 14 | 543 | 3,649 | $255,235 | $113,786 |
| 2021 | 11 | 449 | 2,322 | $132,420 | $82,672 |
| 2020 | 8 | 248 | 353 | $51,050 | $26,167 |
Total Patients
1,867
Total Services
13,599
Medicare Billing
$401,890
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 70 | 6,240 | $249,600 | $115,179 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 355 | $76,525 | $33,382 | 43.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $16,855 | $8,090 | 48.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 51 | $16,440 | $5,314 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 38 | $10,350 | $4,581 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 51 | $7,720 | $3,247 | 42.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 30 | 59 | $7,500 | $3,211 | 42.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $4,305 | $2,441 | 56.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 74 | 169 | $8,450 | $1,890 | 22.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 18 | $3,060 | $919.36 | 30.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 18 | 90 | $10,170 | $576.88 | 5.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 33 | 72 | $1,440 | $408.18 | 28.3% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 27 | 51 | $1,275 | $25.44 | 2.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 31 | 2,821 | $84,625 | $47,509 | 56.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 323 | $74,380 | $31,251 | 42.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 62 | $17,980 | $8,192 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $13,120 | $7,855 | 59.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $9,670 | $5,524 | 57.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 18 | 41 | $12,670 | $4,728 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 44 | $7,040 | $2,838 | 40.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 27 | 41 | $5,500 | $2,128 | 38.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $3,355 | $1,839 | 54.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 52 | $2,520 | $632.28 | 25.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 11 | 11 | $1,790 | $598.23 | 33.4% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 17 | 85 | $21,110 | $484.30 | 2.3% |
About Dr. Hyon Ju Park, MD
Dr. Hyon Ju Park, MD is a Internal Medicine healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083810048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hyon Ju Park, MD has received a total of $13,459 in payments from pharmaceutical and medical device companies, with $3,362 received in 2024. These payments were reported across 677 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($13,360).
As a Medicare-enrolled provider, Park has provided services to 1,867 Medicare beneficiaries, totaling 13,599 services with total Medicare billing of $401,890. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology, Rheumatology
- Location Wynnewood, PA
- Active Since 06/26/2007
- Last Updated 06/26/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083810048
Products in Payments
- Cimzia (Drug) $1,310
- SAPHNELO (Biological) $1,133
- RINVOQ (Biological) $1,006
- Enbrel (Biological) $714.83
- XELJANZ (Drug) $624.14
- ACTHAR (Biological) $575.67
- COSENTYX (Biological) $548.75
- ORENCIA (Biological) $518.78
- EVENITY (Biological) $432.42
- TREMFYA (Drug) $415.33
- BENLYSTA (Biological) $387.65
- Rituxan (Biological) $371.33
- TALTZ (Drug) $359.26
- KEVZARA (Biological) $291.54
- SKYRIZI (Biological) $269.59
- Arcalyst (Drug) $249.38
- Bimzelx (Biological) $241.95
- Tymlos (Drug) $217.60
- COSENTYX (Drug) $202.65
- AMJEVITA (Biological) $179.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wynnewood
Dr. Bonnie Goldmann, M.d, M.D
Internal Medicine — Payments: $127,503
Internal Medicine $127,503
Dr. Ryan Reber, D.o, D.O
Internal Medicine — Payments: $90,073
Internal Medicine $90,073
Amanulla Khaji
Internal Medicine — Payments: $82,548
Internal Medicine $82,548
Dr. David Cohen, Md, MD
Internal Medicine — Payments: $41,001
Internal Medicine $41,001
Dr. M Susan Burke, Md, MD
Internal Medicine — Payments: $40,158
Internal Medicine $40,158
Dr. Amy Smith, M.d, M.D
Internal Medicine — Payments: $12,217
Internal Medicine $12,217